-
公开(公告)号：US20090220550A1
公开(公告)日：2009-09-03
申请号：US11982079
申请日：2007-10-31
Applicant: Joan D. Leonard , Robert W. Tully
Inventor： Joan D. Leonard , Robert W. Tully
CPC classification number: A61K39/0241 , A61K2039/521 , A61K2039/522 , A61K2039/552 , A61K2039/555 , A61K2039/55505 , A61K2039/55566
Abstract: The invention of novel, effective vaccines against Mycoplasma bovis for use in cattle is described. These vaccines demonstrate no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia, joint infections, keratoconjunctivitis and middle ear infections. The novel vaccines also lessen the effect of M. bovis infections on milk production, weight gain and animal health. Methods of diagnosing, characterizing and treating M. bovis infections as specific biotypes are also disclosed. Vaccine compositions made in accordance with the invention may be either of the attenuated or inactivated variety. Vaccines may also include antigens from other pathogens so as to provide a protective immunogenic response to diseases other than those caused by M. bovis.
Abstract translation: 描述了用于牛用于牛支原体的新型有效疫苗的发明。 这些疫苗不表现出不希望的副作用，并且防止牛分枝杆菌相关疾病，如传染性乳腺炎，呼吸性肺炎，关节感染，角膜结膜炎和中耳感染。 新型疫苗也可以减轻牛分枝杆菌感染对牛奶生产，体重增加和动物健康的影响。 还公开了将牛分枝杆菌感染诊断，表征和治疗作为特定生物型的方法。 根据本发明制备的疫苗组合物可以是减毒或灭活的品种。 疫苗还可以包括来自其他病原体的抗原，以便对除牛分枝杆菌引起的疾病以外的疾病提供保护性的免疫原性应答。
-
Patent Agency Ranking
公开(公告)号：US07943153B1
公开(公告)日：2011-05-17
申请号：US09708352
申请日：2000-11-08
Applicant: Joan D. Leonard , Robert W. Tully
Inventor： Joan D. Leonard , Robert W. Tully
CPC classification number: A61K39/0241 , A61K2039/521 , A61K2039/522 , A61K2039/552 , A61K2039/555 , A61K2039/55505 , A61K2039/55566
Abstract: The invention of novel, effective vaccines against Mycoplasma. bovis for use in cattle is described. These vaccines demonstrate no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia, joint infections, keratoconjunctivitis and middle ear infections. The novel vaccines also lessen the effect of M. bovis infections on milk production, weight gain and animal health. Methods of diagnosing, characterizing and treating M. bovis infections as specific biotypes are also disclosed. Vaccine compositions made in accordance with the invention may be either of the attenuated or inactivated variety. Vaccines may also include antigens from other pathogens so as to provide a protective immunogenic response to diseases other than those caused by M. bovis.
Abstract translation: 针对支原体的新型有效疫苗的发明。 描述牛用于牛的牛。 这些疫苗不表现出不希望的副作用，并且防止牛分枝杆菌相关疾病，如传染性乳腺炎，呼吸性肺炎，关节感染，角膜结膜炎和中耳感染。 新型疫苗也可以减少牛分枝杆菌感染对牛奶生产，体重增加和动物健康的影响。 还公开了将牛分枝杆菌感染诊断，表征和治疗作为特定生物型的方法。 根据本发明制备的疫苗组合物可以是减毒或灭活的品种。 疫苗还可以包括来自其他病原体的抗原，以便对除牛分枝杆菌引起的疾病以外的疾病提供保护性的免疫原性应答。
-
公开(公告)号：US20090263427A1
公开(公告)日：2009-10-22
申请号：US11982082
申请日：2007-10-31
Applicant: Joan D. Leonard , Robert W. Tully
Inventor： Joan D. Leonard , Robert W. Tully
IPC: A61K39/04
CPC classification number: A61K39/0241 , A61K2039/521 , A61K2039/522 , A61K2039/552 , A61K2039/555 , A61K2039/55505 , A61K2039/55566
Abstract: The invention of novel, effective vaccines against Mycoplasma bovis for use in cattle is described. These vaccines demonstrate no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia, joint infections, keratoconjunctivitis and middle ear infections. The novel vaccines also lessen the effect of M. bovis infections on milk production, weight gain and animal health. Methods of diagnosing, characterizing and treating M. bovis infections as specific biotypes are also disclosed. Vaccine compositions made in accordance with the invention may be either of the attenuated or inactivated variety. Vaccines may also include antigens from other pathogens so as to provide a protective immunogenic response to diseases other than those caused by M. bovis.
Abstract translation: 描述了用于牛用于牛支原体的新型有效疫苗的发明。 这些疫苗不表现出不希望的副作用，并且防止牛分枝杆菌相关疾病，如传染性乳腺炎，呼吸性肺炎，关节感染，角膜结膜炎和中耳感染。 新型疫苗也可以减轻牛分枝杆菌感染对牛奶生产，体重增加和动物健康的影响。 还公开了将牛分枝杆菌感染诊断，表征和治疗作为特定生物型的方法。 根据本发明制备的疫苗组合物可以是减毒或灭活的品种。 疫苗还可以包括来自其他病原体的抗原，以便对除牛分枝杆菌引起的疾病以外的疾病提供保护性的免疫原性应答。
-
公开(公告)号：US07429389B2
公开(公告)日：2008-09-30
申请号：US10726029
申请日：2003-12-02
Applicant: Joan D. Leonard , Robert W. Tully
Inventor： Joan D. Leonard , Robert W. Tully
CPC classification number: A61K39/0241 , A61K2039/521 , A61K2039/522 , A61K2039/552 , A61K2039/555 , A61K2039/55505 , A61K2039/55566
Abstract: The invention of novel, effective vaccines against Mycoplasma bovis for use in cattle is described. These vaccines demonstrate no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia, joint infections, keratoconjunctivitis and middle ear infections. The novel vaccines also lessen the effect M. bovis infections on milk production, weight gain and animal health. Methods of diagnosing characterizing and treating M. bovis infections as specific biotypes are also disclosed. Vaccine compositions made in accordance with the invention may be either of the attenuated or inactivated variety. Vaccines may also include antigens from other pathogens so as to provide a protective immunogenic response to diseases other than those caused by M. bovis.
Abstract translation: 描述了用于牛用于牛支原体的新型有效疫苗的发明。 这些疫苗不表现出不希望的副作用，并且防止牛分枝杆菌相关疾病，如传染性乳腺炎，呼吸性肺炎，关节感染，角膜结膜炎和中耳感染。 新型疫苗也可以减少牛分枝杆菌感染对牛奶生产，体重增加和动物健康的影响。 还公开了将牛分枝杆菌感染特征化和诊断为特异性生物型的方法。 根据本发明制备的疫苗组合物可以是减毒或灭活的品种。 疫苗还可以包括来自其他病原体的抗原，以便对除牛分枝杆菌引起的疾病以外的疾病提供保护性的免疫原性应答。
-
公开(公告)号：US20080226671A1
公开(公告)日：2008-09-18
申请号：US11982265
申请日：2007-10-31
Applicant: Joan D. Leonard , Robert W. Tully
Inventor： Joan D. Leonard , Robert W. Tully
IPC: A61K39/295 , A61K39/02 , A61P11/00
CPC classification number: A61K39/0241 , A61K2039/521 , A61K2039/522 , A61K2039/552 , A61K2039/555 , A61K2039/55505 , A61K2039/55566
Abstract: The invention of novel, effective vaccines against Mycoplasma. bovis for use in cattle is described. These vaccines demonstrate no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia, joint infections, keratoconjunctivitis and middle ear infections. The novel vaccines also lessen the effect of M. bovis infections on milk production, weight gain and animal health. Methods of diagnosing, characterizing and treating M. bovis infections as specific biotypes are also disclosed. Vaccine compositions made in accordance with the invention may be either of the attenuated or inactivated variety. Vaccines may also include antigens from other pathogens so as to provide a protective immunogenic response to diseases other than those caused by M. bovis.
Abstract translation: 针对支原体的新型有效疫苗的发明。 描述牛用于牛的牛。 这些疫苗不表现出不希望的副作用，并且防止牛分枝杆菌相关疾病，如传染性乳腺炎，呼吸性肺炎，关节感染，角膜结膜炎和中耳感染。 新型疫苗也可以减少牛分枝杆菌感染对牛奶生产，体重增加和动物健康的影响。 还公开了将牛分枝杆菌感染诊断，表征和治疗作为特定生物型的方法。 根据本发明制备的疫苗组合物可以是减毒或灭活的品种。 疫苗还可以包括来自其他病原体的抗原，以便对除牛分枝杆菌引起的疾病以外的疾病提供保护性的免疫原性应答。
-
公开(公告)号：US07416734B2
公开(公告)日：2008-08-26
申请号：US10825391
申请日：2004-04-14
Applicant: Joan D. Leonard , Robert W. Tully
Inventor： Joan D. Leonard , Robert W. Tully
IPC: A61K39/02 , A61K39/00 , A61K39/295 , A61K39/116 , A61K38/00
CPC classification number: A61K39/0241 , A61K2039/521 , A61K2039/522 , A61K2039/552 , A61K2039/555 , A61K2039/55505 , A61K2039/55566
Abstract: The invention of novel, effective vaccines against Mycoplasma bovis for use in cattle is described. These vaccines demonstrate no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia, joint infections, keratoconjunctivitis and middle ear infections. The novel vaccines also lessen the effect of M. bovis infections on milk production, weight gain and animal health. Methods of diagnosing, characterizing and treating M. bovis infections as specific biotypes are also disclosed. Vaccine compositions made in accordance with the invention may be either of the attenuated or inactivated variety. Vaccines may also include antigens from other pathogens so as to provide a protective immunogenic response to diseases other than those caused by M. bovis.
Abstract translation: 描述了用于牛用于牛支原体的新型有效疫苗的发明。 这些疫苗不表现出不希望的副作用，并且防止牛分枝杆菌相关疾病，如传染性乳腺炎，呼吸性肺炎，关节感染，角膜结膜炎和中耳感染。 新型疫苗也可以减少牛分枝杆菌感染对牛奶生产，体重增加和动物健康的影响。 还公开了将牛分枝杆菌感染诊断，表征和治疗作为特定生物型的方法。 根据本发明制备的疫苗组合物可以是减毒或灭活的品种。 疫苗还可以包括来自其他病原体的抗原，以便对除牛分枝杆菌引起的疾病以外的疾病提供保护性的免疫原性应答。
-
-
-
-
-
Search Results
6
records
(took 0.024 seconds)
